Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials.
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure; D001835:Body Weight; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004343:Drug Implants; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007391:International Cooperation; D007435:Intrauterine Devices, Copper / Q000009:adverse effects; D008598:Menstruation / Q000187:drug effects; D009644:Norgestrel / Q000009:adverse effects / Q000494:pharmacology*; D009645:Norgestrienone / Q000009:adverse effects / Q000494:pharmacology*; D009651:Norpregnatrienes / Q000494:pharmacology*; D013997:Time Factors
D004343:Drug Implants; D006454:Hemoglobins; D009651:Norpregnatrienes; D009644:Norgestrel; D009645:Norgestrienone